Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, specializing in long-acting antibodies and antibody combinations for inflammatory bowel disease (IBD) and rheumatic diseases. The Company's pipeline includes investigational extended half-life antibodies targeting a4b7, TL1A, and IL-23. It is advancing a pipeline of monoclonal antibodies (mAbs) for the treatment of IBD and other immune-mediated diseases. The Company's pipeline includes its SKYLINE Phase II platform trial evaluating SPY001, SPY002, SPY003, and pairwise combinations thereof in subjects with moderately to severely active UC and its SKYWAY basket trial evaluating SPY072 in three rheumatic diseases: rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA). SPY001 is a highly potent, highly selective, and humanized monoclonal immunoglobulin G1 investigational antibody designed to bind selectively to the a4b7 integrin being developed for the treatment of IBD (UC and CD).
Find out what a historical investment in Spyre Therapeutics Inc would be worth today using our SYRE stock calculator.
Buying SYRE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Spyre Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in SYRE
What is the ticker symbol of Spyre Therapeutics Inc?
The ticker symbol for Spyre Therapeutics Inc is SYRE.
How much is one share of SYRE?
One share of SYRE is valued at $97.63 as of 20 November 2026.
What is the market capitalisation of Spyre Therapeutics Inc SYRE?
As of 20 November 2026 Spyre Therapeutics Inc has a market cap of $9.64B.
What is the 52-week high for Spyre Therapeutics Inc stock?
The Spyre Therapeutics Inc 52-week high stock price is $110.64.
What is the 52-week low for Spyre Therapeutics Inc stock?
The Spyre Therapeutics Inc 52-week low stock price is $23.01.
Can I buy SYRE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SYRE shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SYRE on Stake
Buy SYRE from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of SYRE from only US$10 with fractional shares